Orgun, L. T. Et Al. 2025. Apparent efficacy of NMDAR antagonist use as a targeted therapy for status epilepticus in an infant with ATP1A2-related developmental epileptic encephalopathy. Seizure , vol.126 , 95-98.

Orgun, L. T., Deniz, A., Güneş, A. S., Akkoyunlu, D., CIRDI, G., GÖK, A., ... KARA, B.(2025). Apparent efficacy of NMDAR antagonist use as a targeted therapy for status epilepticus in an infant with ATP1A2-related developmental epileptic encephalopathy. Seizure , vol.126, 95-98.

Orgun, Leman Et Al. "Apparent efficacy of NMDAR antagonist use as a targeted therapy for status epilepticus in an infant with ATP1A2-related developmental epileptic encephalopathy," Seizure , vol.126, 95-98, 2025

Orgun, Leman T. Et Al. "Apparent efficacy of NMDAR antagonist use as a targeted therapy for status epilepticus in an infant with ATP1A2-related developmental epileptic encephalopathy." Seizure , vol.126, pp.95-98, 2025

Orgun, L. T. Et Al. (2025) . "Apparent efficacy of NMDAR antagonist use as a targeted therapy for status epilepticus in an infant with ATP1A2-related developmental epileptic encephalopathy." Seizure , vol.126, pp.95-98.

@article{article, author={Leman Tekin Orgun Et Al. }, title={Apparent efficacy of NMDAR antagonist use as a targeted therapy for status epilepticus in an infant with ATP1A2-related developmental epileptic encephalopathy}, journal={Seizure}, year=2025, pages={95-98} }